HealthcareServices

Vascular Dementia Market Forecast 2026–2035: How to Leverage Market Growth

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the vascular dementia market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Vascular Dementia Market expected to reach by 2030?

The vascular dementia market size has experienced rapid growth in recent years. It is anticipated to expand from $3.27 billion in 2025 to $3.65 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.8%. This growth observed in the historic period can be attributed to the increasing incidence of stroke-related cognitive decline, a rising prevalence of hypertension and diabetes, the expansion of neurological research programs, improved diagnostic awareness, and the growth in hospital-based dementia care.

The market for vascular dementia is anticipated to experience significant expansion over the coming years. This market is projected to reach a valuation of $5.63 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.4%. Factors contributing to this growth during the projected period include an expanding elderly demographic, increased funding for neurological drug discovery, wider uptake of digital tools for health monitoring, the broadening scope of precision medicine, and a heightened emphasis on managing cognitive health over the long term. Key developments expected during the forecast timeframe encompass a greater emphasis on detecting cognitive disorders early, the increased incorporation of digital tools for cognitive assessment, expanding research into neurodegeneration linked to vascular issues, the broadening of individualized treatment methods, and a stronger focus on preventive care initiatives.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp

What Drivers Are Driving Adoption Within The Vascular Dementia Market?

The increasing incidence of cardiovascular disease is projected to fuel the vascular dementia market moving forward. Cardiovascular diseases encompass a spectrum of conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and hypertension. The escalating prevalence of these diseases is influenced by elements such as unhealthy lifestyles, inadequate dietary practices, physical inactivity, heightened stress levels, an aging global population, and a surge in risk factors like obesity, diabetes, and hypertension. Cardiovascular disease elevates the risk of vascular dementia by impeding blood flow to the brain, leading to cognitive impairment and damage to brain cells due to insufficient oxygen and nutrient supply. For example, in September 2024, data published by the British Heart Foundation, a UK-based cardiovascular research charity, revealed that in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, equating to over 170,000 deaths annually, or roughly 480 deaths each day, which means one death occurs every three minutes. Thus, the growing prevalence of cardiovascular diseases is a key driver for the vascular dementia market.

How Is The Vascular Dementia Market Organized Into Various Segments?

The vascular dementia market covered in this report is segmented –

1) By Product: Small Molecules / Drugs, Lifestyle And Nutraceutical Interventions, Rehabilitation Therapies

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By End User: Hospitals And Clinics, Rehabilitation Centers, Specialty Clinics

Subsegments:

1) By Small Molecules Or Drugs: Antihypertensives, Anti-diabetic agents, Lipid-lowering agents, Anti-inflammatory agents, Neuroprotective small molecules

2) By Lifestyle And Nutraceutical Interventions: Vitamins & Supplements, Omega-3 Or DHA formulations, Antioxidants

3) By Rehabilitation Therapies: Cognitive enhancers, Physical therapy programs, Occupational therapy aids

Which Trends Are Guiding The Evolution Of The Vascular Dementia Market?

Leading companies within the vascular dementia market are concentrating on creating innovative treatments, such as multimodal therapies, to maintain their market standing. Multimodal therapies encompass the integration of various treatment methods, like medications, physical therapy, and psychological interventions, to provide comprehensive care for a condition. For instance, in January 2023, Moleac, a Singapore-based biopharmaceutical company, introduced CognivAiD, an evidence-based treatment specifically formulated for vascular dementia (VaD), a condition where therapeutic choices are scarce. This product incorporates active extracts from ginkgo, ginseng, and saffron, which have demonstrated significant efficacy in slowing cognitive decline among VaD patients. CognivAiD’s distinct multimodal action targets essential mechanisms of vascular dementia, including vascular protection, vasoregulation, and neuroinflammation. Backed by extensive clinical trials and a strong safety profile, CognivAiD offers a hopeful new treatment option for individuals affected by VaD.

Who Are The Prominent Global Companies Shaping The Vascular Dementia Market Landscape?

Major companies operating in the vascular dementia market are Charsire Biotechnology Corp, ProNeurogen Therapeutics, Resverlogix Corp, Cyclerion Therapeutics Inc, CSPC-NBP Pharma, Johnson & Johnson Services Inc, Materia Medica Holding, Eisai Co Ltd, Shineway Pharmaceutical, Merz Pharma, Ever Neuro Pharma GmbH, Zhejiang Otsuka Pharma, Pfizer Inc, Biogen Inc, Novartis AG, Aurobindo Pharma, Sun Pharmaceutical Industries Ltd, Teva Pharmaceuticals, Zydus Cadila, Eli Lilly and Company

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

Which Region Currently Holds The Largest Share Of The Vascular Dementia Market?

North America was the largest region in the vascular dementia market in 2025. The regions covered in the vascular dementia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Vascular Dementia Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20998&type=smp

Browse Through More Reports Similar to the Global Vascular Dementia Market 2026, By The Business Research Company

Vascular Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-imaging-global-market-report

Peripheral Artery Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Peripheral Arterial Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795